La vendita allo scoperto per K92 Mining dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di K92 Mining. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

K92 Mining (OTC:KNTNF) Azioni, Report sulle vendite allo scoperto

K92 Mining Inc is engaged in the exploration, development, and mining of mineral deposits near the mine, including Blue Lake, in Papua New Guinea.

K92 Mining Inc

RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) reported worse-than-expected third-quarter financial results on Tuesday.
Sales declined 3% year over year to $1.48 billion, missing the consensus of $1.51 billion. Adjusted EPS was 35 cents, missing the consensus of 49 cents.
Frank C. Sullivan, RPM chairman and CEO said, "Unseasonably cold weather in the southern U.S. and wildfires in the west reduced demand in geographies that typically have more construction and outdoor project activity in winter months."
"As we look toward the fourth quarter, macroeconomic conditions are challenging, but we are seeing pockets of positive momentum and are leveraging our focus on repair and maintenance in both construction and consumer end markets. As demonstrated in prior economic cycles, the ability of our products and services to extend asset life becomes even more attractive to end users when budgets are tight."
For the fourth quarter, RPM expects consolidated sales to remain flat compared to prior-year records.
RPM shares dipped 9.1% to close at $96.97 on Tuesday.
These analysts made changes to their price targets on RPM International following earnings announcement.
<ul>
<li>Baird analyst Ghansham Panjabi maintained RPM Intl with a Neutral and lowered the price target from $125 to $110.</li>
<li>BMO Capital analyst John McNulty maintained the stock with an Outperform rating and lowered the price target from $154 to $126.</li>
<li>Morgan Stanley analyst Vincent Sinisi maintained RPM with an Equal-Weight rating and cut the price target from $125 to $113.</li>
</ul>
Considering buying RPM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="590" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-1024x590.png" alt="" class="wp-image-863776" style="width:522px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-1024x590.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54-768x443.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09085126/image-54.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

RPM International Analysts Slash Their Forecasts After Downbeat Earnings

BMO Capital analyst Andrew Strelzik maintains Dave &amp; Buster's Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) with a Outperform and lowers the price target from $47 to $30.

PLAY

BMO Capital Maintains Outperform on Dave & Buster's Enter, Lowers Price Target to $30

Scotiabank analyst Ben Isaacson upgrades CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) from Sector Underperform to Sector Perform and maintains the price target from $81 to $81.

Upgrades

Scotiabank Upgrades CF Industries Holdings to Sector Perform, Maintains Price Target to $81

Global fintech firm Broadridge Financial Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BR#NYSE">BR</a>) <a href="https://www.benzinga.com/pressreleases/25/04/n44704954/broadridge-collaborates-with-fnality-to-enable-real-time-settlement-for-intraday-repo-transactions">revealed it has concluded a successful joint effort</a> with blockchain payments company Fnality. 
The collaboration proved that Broadridge's Distributed Ledger Repo (DLR) platform can operate with Fnality's Payment System (FnPS), highlighting how tokenized assets can transform transaction processes in global financial markets.
Fnality is building a network of regulated wholesale payment systems powered by distributed ledger technology, each overseen by its local central bank. 
These systems, called Fnality Payment Systems (FnPS), allow participants to use digital versions of central bank funds for instant transactions. 
The partnership sets the stage for instant intraday repo settlements by utilizing tokenized money backed by central bank reserves.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44703031/this-beverage-maker-tobacco-company-and-packaged-food-giant-outshine-in-a-recession">This Beverage Maker, Tobacco Company And Packaged Food Giant Outshine In A Recession</a>
The combined use of Broadridge's DLR platform and Fnality's FnPS network illustrates how real-time delivery versus payment (DvP) can be achieved in repo markets. 
Leveraging tokenized funds tied to central bank reserves as the settlement foundation, the approach offers enhanced transaction speed and security. 
This development meets a critical industry demand for better liquidity management and lower risk in both the U.S. and European financial systems.
With planned rollouts in major markets, FnPS aims to support 24/7 cross-currency payments and atomic settlement, offering secure, institutional-grade digital cash for emerging digital asset markets.
Broadridge views this milestone as a major step toward broadening its digital footprint across Europe. The company aims to grow its DLR client base by offering near-instant settlement solutions to meet the increasing demand for speed and security in financial markets.
For its part, Fnality plans to extend its regulated blockchain-based wholesale payments infrastructure beyond the UK, targeting the U.S. as a critical expansion region.
Broadridge&#8217;s second-quarter 2025 sales grew <a href="https://www.benzinga.com/25/01/43394380/broadridge-financial-q2-beats-estimates-reaffirms-outlook">13.1% year-on-year to $1.589 billion</a>.
Broadridge provides technology solutions that support investing, corporate governance, and financial communications. Its platforms facilitate daily trades exceeding $10 trillion in securities and connect public companies with investors worldwide.
Price Action: BR shares closed lower by 1.32% at $217.22 on Tuesday.
Read Next: <a href="https://www.benzinga.com/tech/25/04/44695622/amazon-touts-ai-milestone-says-new-model-outshines-gpt-4o-in-real-time-speech">Amazon Touts AI Milestone, Says New Model Outshines GPT-4o In Real-Time Speech</a>
Photo: Shutterstock

General

Broadridge And Fnality Unlock Blockchain-Based Repo Settlements

Neogen Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) reported third-quarter 2025 adjusted EPS of 10 cents on Wednesday, down from 12 cents a year ago, missing the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus of 11 cents</a>.
The company reported sales of $220.98 million, down 3.4% year over year, missing the consensus of $224.88 million.
Core revenue, which excludes the impacts of foreign currency translation and acquisitions completed and product lines discontinued in the last 12 months, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44707568/neogen-announces-third-quarter-2025-results" rel="noreferrer noopener">increased by 0.2%</a>.
Acquisitions and discontinued product lines had a negative impact of 0.5% while foreign currency had a negative impact of 3.1%.
The gross margin was 49.9% down from 51.1% a year ago, mainly due to lower revenue and higher integration costs. Excluding integration and restructuring costs, gross margin was 51.5% in the third quarter compared to 51.8% in the prior-year quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44698463/cartesian-therapeutics-reports-strong-12-month-data-for-lead-cell-therapy-in-myasthenia-gravis-patients" rel="noreferrer noopener">Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients</a>
Third-quarter Adjusted EBITDA was $48.5 million, representing an adjusted EBITDA margin of 22%, compared with $52.7 million and a margin of 23% a year earlier.
Revenues for the Food Safety segment were $152.7 million, a decrease of 3.2%, consisting of 1.5% core growth, a negative 0.3% impact from discontinued product lines, and a negative foreign currency impact of 4.4%.
<ul>
<li>Core growth was driven largely by biosecurity and bacterial and general sanitation product categories, which benefited from strong growth in pathogen detection products.</li>
</ul>
Revenues for the Animal Safety segment were $68.2 million, a decrease of 4%, consisting of a 2.6% core revenue decline, an unfavorable 0.4% foreign currency impact and a negative 1% impact from discontinued product lines.
<ul>
<li>Growth was led by the animal care and other and biosecurity product categories, particularly in small-animal supplements, rodent control, and cleaner and disinfectant products, and offset by a decline in the vet instruments product category.</li>
</ul>
The company&#8217;s Genomics business experienced a core revenue decline in the mid-single-digit range. Increased sales into bovine markets were offset by declines in other areas, consistent with the focused restructuring activities executed in the second quarter.
Guidance: The company is updating its full-year outlook, primarily due to lower-than-expected third-quarter results, the rising level of macroeconomic uncertainty affecting the company&#8217;s end markets, and the expected impact of tariffs in the fourth quarter.
Neogen expects fiscal year 2025 sales of approximately $895 million, down from prior guidance of $905 million-$925 million and consensus of $910.23 million.
The company forecasts 2025 adjusted EBITDA of approximately $195 million compared to prior guidance of $205 million-$215 million.
Management Update: Neogen CEO John Adent will be stepping down after eight years the company. Adent will continue to serve in his existing roles until his successor <a href="https://www.benzinga.com/pressreleases/25/04/b44707614/neogen-announces-ceo-transition" target="_blank" rel="noreferrer noopener">has been appointed</a>.
Price Action: NEOG stock is down 17.6% at $5.80 during the premarket session at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44698379/argenxs-flagship-drug-vyvgart-shows-sustained-disease-control-in-rare-neuromuscular-disease-patients" target="_blank" rel="noreferrer noopener">Argenx&#8217;s Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients</a></li>
</ul>
Photo: Shutterstock/MacroEcon

Guidance

Health Care

Management

Movers

NEOG

Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays cut Americold Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) price target from $26 to $21. Barclays analyst Anthony Powell upgraded the stock from Equal-Weight to Overweight. Americold Realty Trust shares closed at $17.50 on Tuesday. <a href="https://www.benzinga.com/quote/COLD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan slashed the price target for PTC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTC#NASDAQ">PTC</a>) from $210 to $160. JP Morgan analyst Alexei Gogolev downgraded the stock from Overweight to Neutral. PTC shares closed at $136.74 on Tuesday. <a href="https://www.benzinga.com/quote/PTC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies lowered Xenia Hotels &amp; Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) price target from $18 to $10. Jefferies analyst David Katz downgraded the stock from Buy to Hold. Xenia Hotels shares closed at $9.22 on Tuesday. <a href="https://www.benzinga.com/quote/XHR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) from $132 to $122. Piper Sandler analyst Paul Newsome maintained an Overweight rating. Goosehead Insurance shares closed at $103.90 on Tuesday. <a href="https://www.benzinga.com/quote/GSHD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Oppenheimer cut the price target for Freshworks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) from $24 to $19. Oppenheimer analyst Brian Schwartz maintained an Outperform rating. Freshworks shares closed at $12.08 on Tuesday. <a href="https://www.benzinga.com/quote/FRSH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho raised UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) price target from $600 to $650. Mizuho analyst Ann Hynes maintained an Outperform rating. UnitedHealth shares settled at $553.08 on Tuesday. <a href="https://www.benzinga.com/quote/UNH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) price target from $17 to $16. Morgan Stanley analyst Alex Straton maintained an Equal-Weight rating. Levi Strauss shares closed at $12.42 on Tuesday. <a href="https://www.benzinga.com/quote/LEVI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho slashed Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) price target from $285 to $255. Mizuho analyst James Lee maintained an Outperform rating. Amazon shares closed at $170.66 on Tuesday.  <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital cut the price target for RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) from $154 to $126. BMO Capital analyst John McNulty maintained an Outperform rating. RPM shares settled at $96.97 on Tuesday. <a href="https://www.benzinga.com/quote/RPM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs raised Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) price target from $157 to $172. Goldman Sachs analyst Asad Haider upgraded the stock from Neutral to Buy. Johnson &amp; Johnson shares closed at $150.00 on Tuesday. <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying AMZN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-1024x584.png" alt="" class="wp-image-863746" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09084430/image-53.png 1080w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

AMZN

COLD

FRSH

GSHD

LEVI

Amazon.com To $255? Here Are 10 Top Analyst Forecasts For Wednesday

Subcutaneous DARZALEX&reg; is co-formulated with Halozyme&#39;s ENHANZE&reg; drug delivery technology

Biotech

HALO

Halozyme Therapeutics Announces European Commission Approved Subcutaneous DARZALEX-Based Quadruplet Regimen For Treatment Of Patients With Newly Diagnosed Multiple Myeloma, Regardless Of Transplant Eligibility

Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) with a Buy and maintains $46 price target.

Reiteration

COLL

Needham Reiterates Buy on Collegium Pharmaceutical, Maintains $46 Price Target

OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) reported quarterly losses of $(1.17) per share. This is a 178.57 percent decrease over losses of $(0.42) per share from the same period last year. The company reported $5.78 million in sales this quarter. This is a 0.46 percent decrease over sales of $5.81 million the same period last year.

OceanPal Q4 EPS $(1.17) Down From $(0.42) YoY, Sales $5.78M Down From $5.81M YoY

Apollo CEO Marc Rowan Says I Expect Over The Next 90 Days We'll See The Beginnings Of Countries Coming To Make Deals

SNDL Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) ("SNDL") and 1CM Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/EPIC#CSE">EPIC</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/MILFF#OTCQB">MILFF</a>) (FSE: IQ70) ("1CM") are&nbsp;pleased to announce that they have&nbsp;entered into an arrangement&nbsp;agreement (the "Agreement") pursuant to which SNDL will acquire 32&nbsp;cannabis retail stores&nbsp;(the "Transaction")&nbsp;operating under the Cost Cannabis and T Cannabis banners in Ontario, Alberta and Saskatchewan (the "1CM Stores"). Unless otherwise specified herein, all amounts are in Canadian currency.
Under&nbsp;the terms of&nbsp;the Agreement, SNDL will acquire, with the option to assign, the 1CM Stores for total consideration (the "Purchase Price") of $32.2&nbsp;million in cash, subject to certain adjustments at the closing of the Transaction (the "Closing").&nbsp;The 1CM Stores are comprised of 2&nbsp;stores in Alberta, 3 stores&nbsp;in Saskatchewan and 27&nbsp;stores located in Ontario. The&nbsp;1CM&nbsp;Stores&nbsp;generated annual revenue of an aggregate&nbsp;of $53 million&nbsp;the fiscal year ended August 31, 2024 with 30 active stores at the fiscal year end.&nbsp;The acquisition of the 1CM Stores will bring SNDL's&nbsp;total owned and franchised cannabis retail store count to 219.

CSE:EPIC

MILFF

SNDL

SNDL Inc. To Acquire 32 Cannabis Retail Stores Operating Under Cost Cannabis And T Cannabis Banners In Ontario, Alberta, And Saskatchewan From 1CM Inc. For $32.2M, Increasing SNDL's Total Retail Store Count To 219

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) with a Buy and maintains $60 price target.

Needham Reiterates Buy on Avidity Biosciences, Maintains $60 Price Target

Citigroup analyst Ryan Levine upgrades Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) from Neutral to Buy and lowers the price target from $334 to $232.

Citigroup Upgrades Constellation Energy to Buy, Lowers Price Target to $232

Electronics manufacturer Foxconn Technology Co <a href="https://www.benzinga.com/topic/japan" target="_blank" rel="noreferrer noopener">is eyeing Japanese</a> automakers, including Nissan Motor Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANY#OTC">NSANY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NSANF#OTC">NSANF</a>), to form a Japan-Taiwan alliance.
According <a href="https://asia.nikkei.com/Editor-s-Picks/Interview/Taiwan-s-Foxconn-hopes-to-work-with-Nissan-others-on-EV-production" target="_blank" rel="noreferrer noopener">to</a> Nikkei Asia, Foxconn EV chief strategy officer Jun Seki revealed the agreement during a <a href="https://www.benzinga.com/markets/asia/25/03/44508263/apple-and-nvidia-supplier-foxconn-to-present-ev-plans-at-japan-seminar-following-mitsubishi-deal-report" target="_blank" rel="noreferrer noopener">Tokyo seminar on</a> Tuesday.
Foxconn, also known as Hon Hai Precision (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HNHAY#OTC">HNHAY</a>), is currently competing with Chinese brands focused on battery-powered vehicles, looking to win market share in Europe, Brazil, and Thailand.
Foxconn, an Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) supplier, plans to launch an electric bus and a battery-powered microbus in Japan in 2027, Reuters cited Seki.
Also Read: <a href="https://www.benzinga.com/25/04/44631510/asml-to-boost-japan-workforce-5x-amid-global-race-for-advanced-semiconductor-tech" target="_blank" rel="noreferrer noopener">Chip Equipment Maker ASML To Boost Japan Workforce 5x Amid Global Race For Advanced Semiconductor Tech</a>
It focuses on providing business-to-business services with EV operations instead of targeting consumers directly.
Seki told Reuters that Foxconn should be part of a potential broader partnership with Honda Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>), Nissan, and Mitsubishi Motors (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MTSUY#OTC">MTSUY</a>) and confirmed that Foxconn was finalizing a deal with Mitsubishi to supply it with EVs.
Foxconn was working with Mitsubishi, Seki said during Wednesday&#8217;s event.
President Donald Trump&#8217;s 25% auto tariff&nbsp;<a target="_blank" href="https://www.benzinga.com/news/25/03/44522387/japanese-automakers-face-29-billion-tariff-hit-nissan-mazda-subaru-most-at-risk-says-analyst" rel="noreferrer noopener">threatens to disrupt</a> the global automotive industry, with analysts warning of sharp price increases and declining sales.
Goldman Sachs&nbsp;expected imported&nbsp;vehicle prices to surge by $5,000 to $15,000, while even U.S.-built cars could see cost hikes of $3,000 to $8,000 due to foreign-made parts. According to analyst Akira Kishimoto, Japanese automakers could face a potential hit of 4.46 trillion yen (about $29.44 billion).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/asia/25/04/44668137/nio-power-in-deal-talks-with-tesla-battery-supplier-catl" target="_blank" rel="noreferrer noopener">Nio Power In Deal Talks With Tesla Battery Supplier CATL</a></li>
</ul>
Image: Shutterstock

Asia

Global

Tech

Media

AAPL

HNHAY

MTSUY

NSANF

NSANY

Foxconn Eyes Nissan, Mitsubishi In Japan EV Push To Counter China's Growing Auto Threat

Needham analyst Gil Blum reiterates Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Buy and maintains $42 price target.

RCKT

Needham Reiterates Buy on Rocket Pharmaceuticals, Maintains $42 Price Target

Needham analyst Mike Matson reiterates Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) from Hold to Hold.

INGN

Needham Reiterates Hold on Inogento Hold

Constellation Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) will release its fourth-quarter earnings results after the <a href="https://www.benzinga.com/quote/STZ/earnings">closing bell on Wednesday, April 9.</a>
Analysts expect the company to report quarterly earnings at $2.28 per share, up from $2.26 per share in the year-ago period. Constellation Brands projects to report quarterly revenue at $2.13 billion, compared to $2.14 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 3, Roth MKM analyst Bill Kirk maintained Constellation Brands with a Buy rating and lowered the price target from $284 to $256.
With the recent buzz around the company, some investors may be eyeing potential gains from its dividends, too. As of now, Constellation offers an annual dividend yield of 2.36%, which is a quarterly dividend of $1.01 per share ($4.04 a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $253,876 or around 1,485 shares. For a more modest $100 per month or $1,200 per year, you would need $50,775 or around 297 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($4.04 in this case). So, $6,000 / $4.04 = 1,485 ($500 per month), and $1,200 / $4.04 = 297 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
STZ Price Action: Shares of Constellation Brands fell 0.9% to close at $170.96 on Tuesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a></li>
</ul>
Photo: Shutterstock

Long Ideas

How To Earn $500 A Month From Constellation Brands Stock Ahead Of Q4 Earnings

Loop Capital analyst Garik Shmois initiates coverage on CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) with a Buy rating and announces Price Target of $114.

Initiation

Loop Capital Initiates Coverage On CRH with Buy Rating, Announces Price Target of $114

Collaboration to Deliver Agile, High-Performance Satellite Platforms for Commercial, Defense, and Government Customers Worldwide.
Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) (the "Company" or "Sidus"), an innovative, agile space mission enabler, today announced the signing of a Memorandum of Understanding (MOU) with Berlin-based <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.reflexaerospace.com%2F&amp;esheet=54235839&amp;newsitemid=20250409176057&amp;lan=en-US&amp;anchor=Reflex+Aerospace+GmbH&amp;index=1&amp;md5=afba4e503a4e3133f85e34f6a13e5503">Reflex Aerospace GmbH</a>, a cutting-edge European designer and manufacturer of high-performance, tailor-made satellites. The agreement was officially signed during the Space Foundation's <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.spacesymposium.org%2F%3Fhsa_acc%3D2708741139%26hsa_cam%3D21151499714%26hsa_grp%26hsa_ad%26hsa_src%3Dx%26hsa_tgt%26hsa_kw%26hsa_mt%26hsa_net%3Dadwords%26hsa_ver%3D3%26gad_source%3D1%26gclid%3DCjwKCAjwktO_BhBrEiwAV70jXjhoRCJMelc5pH70ViS12WtQHk2POOpBfiindDSzay0m3mryFTX-JxoCRGUQAvD_BwE%26utm_term%3D%26utm_campaign%3DTSF%2B-%2BPmax%2B-%2BSymposium%2B-%2BLivestream%26utm_source%3Dadwords%26utm_medium%3Dppc&amp;esheet=54235839&amp;newsitemid=20250409176057&amp;lan=en-US&amp;anchor=40th+Space+Symposium&amp;index=2&amp;md5=52e9800fa4779750f799c402c8c0d660">40th Space Symposium</a> in Colorado Springs, CO, formalizing a partnership that began with a <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.sidusspace.com%2Fnews-events%2Fpress-releases%2Fdetail%2F211%2Fsidus-space-and-reflex-aerospace-sign-letter-of-intent-at&amp;esheet=54235839&amp;newsitemid=20250409176057&amp;lan=en-US&amp;anchor=Letter+of+Intent&amp;index=3&amp;md5=bcfcafd2b86cb3dfc69f99894ffc89d9">Letter of Intent</a> at the Space Tech Expo Europe in November 2024. The agreement formally establishes the framework to form a U.S.-based Joint Venture focused on delivering flexible, cost-effective, and high-performance solutions to meet diverse customer needs while strengthening their presence in global markets.
Under the agreement, Sidus and Reflex will jointly develop and manufacture integrated satellite platforms leveraging Sidus' mission operations, technology integration and advanced manufacturing expertise alongside Reflex's rapid satellite development capabilities and high-performance components. The collaboration will target U.S. and European markets across defense, commercial, and government sectors, with both companies contributing to production, business development, and market distribution.

SIDU

Sidus Space And Reflex Aerospace Sign MOU To Establish U.S.-Based Joint Venture For Developing Agile Satellite Platforms Targeting Commercial, Defense, And Government Markets Worldwide, Strengthening Global Presence And Offering Flexible, Cost-Effective Solutions

The Simply Good Foods Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>) shares are <a href="https://www.benzinga.com/premarket">trading higher in premarket</a> on Wednesday after the second-quarter fiscal 2025 earnings.
The company, led by CEO Geoff Tanner, reported<a href="https://www.benzinga.com/pressreleases/25/04/g44707558/the-simply-good-foods-company-reports-fiscal-second-quarter-2025-financial-results-and-reaffirms-f"> second-quarter FY25 sales growth of 15%</a> year-on-year to $359.65 million. It beat the analyst consensus estimate of $354.4 million.
OWYN net sales contributed $33.8 million, or 10.8%, to reported net sales growth, while organic net sales grew 4.4%, driven by Quest.
Gross profit was $130.1 million, an 11.4% increase, and gross margin contracted 120 basis points year over year to 36.2%.
Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44703031/this-beverage-maker-tobacco-company-and-packaged-food-giant-outshine-in-a-recession">This Beverage Maker, Tobacco Company And Packaged Food Giant Outshine In A Recession</a>
Operating expenses rose 9.6% to $75.4 million. Operating margin was 15.2%.
Adjusted EBITDA increased 17.6% Y/Y to $68 million.
Net income of $36.7 million improved by 10.9% from $35.9 million last year. Adjusted EPS of 46 cents beat the consensus estimate of 40 cents.
The company generated $63.3 million in operating cash flow during the six-month period and ended the second quarter with cash and equivalents totaling $103.6 million.
Outlook Reaffirmed: SMPL continues to expect FY25 net sales to grow 8.5% to 10.5%.
Adjusted EBITDA is expected to increase 4% to 6%.
Price Action: SMPL shares traded higher by 3.04% at $34.20 in premarket at last check Wednesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44694350/intuitive-machines-taps-spacex-for-2027-lunar-mission-stock-gains">Intuitive Machines Taps SpaceX For 2027 Lunar Mission, Stock Gains</a></li>
</ul>
Image: Shutterstock

Comments

K92 Mining

Vendite allo scoperto

K92 Mining (OTC:KNTNF) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO